These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 18584941)
21. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129 [TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421 [TBL] [Abstract][Full Text] [Related]
23. [Clinical studies on renal pelvic and ureteral carcinoma]. Akino H; Ishida H; Ito Y; Tanase K; Isomatsu Y; Muranaka K; Mori H; Kanamaru H; Okada K Hinyokika Kiyo; 1997 Apr; 43(4):257-62. PubMed ID: 9161851 [TBL] [Abstract][Full Text] [Related]
24. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Patel HR Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074 [No Abstract] [Full Text] [Related]
25. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Jebar AH; Hurst CD; Tomlinson DC; Johnston C; Taylor CF; Knowles MA Oncogene; 2005 Aug; 24(33):5218-25. PubMed ID: 15897885 [TBL] [Abstract][Full Text] [Related]
26. Mutations of fibroblast growth factor receptor 3 gene (FGFR3) in transitional cell carcinoma of urinary bladder in Thai patients [Revision-2a]. Jantip J; Tanthanuch M; Kanngurn S; Karnchanawanichkul W; Pripatnanont C; Sangkhathat S; Thongsuksai P J Med Assoc Thai; 2013 Aug; 96(8):976-83. PubMed ID: 23991606 [TBL] [Abstract][Full Text] [Related]
27. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805 [TBL] [Abstract][Full Text] [Related]
28. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Touijer K Eur Urol; 2009 Jun; 55(6):1409. PubMed ID: 19299068 [No Abstract] [Full Text] [Related]
29. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder. Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494 [TBL] [Abstract][Full Text] [Related]
30. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Autorino R; Falsaperla M Eur Urol; 2009 Jun; 55(6):1408. PubMed ID: 19299070 [No Abstract] [Full Text] [Related]
31. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters. Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538 [TBL] [Abstract][Full Text] [Related]
32. Chromosome changes in bladder cancer: clinical and other correlations. Sandberg AA Cancer Genet Cytogenet; 1986 Jan; 19(1-2):163-75. PubMed ID: 3455662 [TBL] [Abstract][Full Text] [Related]
33. FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis. Hernández S; López-Knowles E; Lloreta J; Kogevinas M; Jaramillo R; Amorós A; Tardón A; García-Closas R; Serra C; Carrato A; Malats N; Real FX Clin Cancer Res; 2005 Aug; 11(15):5444-50. PubMed ID: 16061860 [TBL] [Abstract][Full Text] [Related]
34. [A clinical study of renal pelvic and ureteral cancer associated with bladder cancer]. Sakaue K; Kakimoto K; Oda M; Kajikawa J; Koide T; Kobayashi Y Hinyokika Kiyo; 1996 Feb; 42(2):91-4. PubMed ID: 8712094 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of transitional cell tumors of the bladder and upper urinary tract. Kvist E; Lauritzen AF; Bredesen J; Luke M; Sjølin KE Cancer; 1988 May; 61(10):2109-12. PubMed ID: 3359407 [TBL] [Abstract][Full Text] [Related]
36. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Joudi FN Eur Urol; 2008 Mar; 53(3):579. PubMed ID: 17804153 [No Abstract] [Full Text] [Related]
37. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828 [TBL] [Abstract][Full Text] [Related]
38. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306 [TBL] [Abstract][Full Text] [Related]
39. Editorial comment on: FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Montironi R Eur Urol; 2007 Sep; 52(3):768. PubMed ID: 17240042 [No Abstract] [Full Text] [Related]
40. [A clinical study of tumor of the renal pelvis and ureter]. Kawashima K; Nakata S; Shimizu N; Matsuo Y; Imai K; Kobayashi M; Umeyama T; Saruki K; Yamanaka H; Suzuki K Hinyokika Kiyo; 1988 Mar; 34(3):429-35. PubMed ID: 3389289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]